Integrum AB Reports Earnings Results for the Fourth Quarter and Full Year Ended April 30, 2024 - Marketscreener.com
| INTEG-B Stock | SEK 18.10 0.30 1.69% |
About 50% of Integrum's investors are presently thinking to get in. The analysis of current outlook of investing in Integrum AB Series suggests that some traders are interested regarding Integrum's prospects. The current market sentiment, together with Integrum's historical and current headlines, can help investors time the market. In addition, many technical investors use Integrum AB Series stock news signals to limit their universe of possible portfolio assets.
Integrum |
Integrum AB Reports Earnings Results for the Fourth Quarter and Full Year Ended April 30, 2024 Marketscreener.com
Read at news.google.com
 |
Integrum Fundamental Analysis
We analyze Integrum's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Integrum using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Integrum based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Integrum is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Integrum AB Series Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Integrum stock to make a market-neutral strategy. Peer analysis of Integrum could also be used in its relative valuation, which is a method of valuing Integrum by comparing valuation metrics with similar companies.
Peers
Integrum Related Equities
| CANTA | Cantargia | 1.19 | ||||
| BIOVIC-B | Biovica International | 0.56 | ||||
| CRAD-B | C Rad | 0.51 | ||||
| SUS | Surgical Science | 2.48 | ||||
| BONEX | Bonesupport Holding | 7.39 |
Complementary Tools for Integrum Stock analysis
When running Integrum's price analysis, check to measure Integrum's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrum is operating at the current time. Most of Integrum's value examination focuses on studying past and present price action to predict the probability of Integrum's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrum's price. Additionally, you may evaluate how the addition of Integrum to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |